Pharma-nutra divisions narrow as CPhI exhibitors recognize cross-industry applications

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Dairy proteins have long been a staple of diets globally but things are changing. Consumers are increasingly concerned about animal welfare, production standards and the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Lonza and Bioqube Ventures, a European venture capital firm with a dual investment model including venture creation, have partnered to develop and manufacture biologics... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Health claims play a crucial role in communicating with consumers but different regional approaches reveal a fractured scene. Experts from Gencor, Lonza,... Read More

FormattedPicture

BUSINESS NEWS

ADM has completed its acquisition of Deerland Probiotics & Enzymes. While the financial details of the purchase have not been released, the agri-food giant is... Read More

FormattedPicture

BUSINESS NEWS

Chr. Hansen and Lonza’s joint venture Bacthera and microbiome therapeutics company Seres Therapeutics are teaming up to manufacture SER-109, Seres’ lead... Read More

trans